Search results
Two High Conviction Dividend Buys For This Upside-Down Market
Seeking Alpha· 3 days agoFOMO is driving stock market decisions, especially with meme stocks like GameStop and high-flying AI...
Playing without Cameron Brink, Sparks can't keep up in loss to Liberty
Los Angeles Times· 4 days agoSabrina Ionescu scored 31 points and Jonquel Jones added 22 to help the New York Liberty beat the...
Erik Canuel, ‘Bon Cop, Bad Cop’ Director, Dies at 63
The Hollywood Reporter· 6 days agoVeteran Quebec director Erik Canuel, best known for his box office hit Bon Cop, Bad Cop, has died. Canuel died on June 15 in Montreal after complications...
Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel...
Morningstar· 5 days agoALPHA3 Trial Has the Potential to Position Cema-cel as Part of First Line (1L) Treatment for LBCL to Improve Cure RatesFirst Prospective Trial to Incorporate the Foresight Diagnostics’s Investigational CLARITY™ Test to Identify Patients with LBCL Who
Area groups offer support for alcoholism, eating disorders, pregnancy and more
Grand Island Independent· 7 days agoNote: For a schedule of meetings that address addictions in central Nebraska, call the Central...
'This is not a journey you take alone' | Knoxville coffee shop employs people who have recovered...
WBIR-TV Knoxville· 7 days agoAt Metro Drug Coalition's new coffee shop, "soberistas" make coffee and connections. Gateway Coffee...
Roswell Park Insights on Role of Exportin 1 Protei | Newswise
Newswise· 5 days agoResearch by Hemn Mohammadpour, DVM, PhD, and colleagues at Roswell Park Comprehensive Cancer Center offers new insights into tumor biology and may lay the
Amgen Inc. (NASDAQ:AMGN) Stake Lowered by First PREMIER Bank
ETF DAILY NEWS· 22 hours agoFirst PREMIER Bank reduced its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.1% during the 1st quarter, according to the company in its most recent filing with the Securities ...
FDA Expands Orphan Drug Designation for SurVaxM, I | Newswise
Newswise· 4 days agoBUFFALO, N.Y. — The U.S. Food and Drug Administration (FDA) has expanded orphan drug designation for SurVaxM, a brain cancer immunotherapy born in the labs of Roswell Park Comprehensive Cancer ...
StockNews.com Downgrades Bristol-Myers Squibb (NYSE:BMY) to Buy
ETF DAILY NEWS· 6 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) was downgraded by research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a note issued to investors on Monday. BMY ...